ARPP-21 Antibodies

Santa Cruz Biotechnology features a diverse variety of ARPP-21 monoclonal antibodies for research focused on understanding ARPP-21's role in cellular processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ARPP-21, or cAMP-regulated phosphoprotein 21, plays a vital role in regulating neuronal signaling pathways and synaptic plasticity. ARPP-21 functions are essential for modulating the effects of dopamine and other neurotransmitters, making it significant in neurobiology research. ARPP-21 has emerged as a potential therapeutic target for neurological disorders. Research involving ARPP-21 can provide valuable insights into various physiological and pathological processes, including addiction and cognitive function. Investigating ARPP-21 expression patterns and interactions helps advance understanding of neuronal communication and regulation. ARPP-21 studies contribute to expanding knowledge of brain function and development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of neurological processes and potential therapeutic applications.